Menú
  • Inici
  • Bogdan Vlacho Vlacho
avatar_investigadors.jpg

Bogdan Vlacho Vlacho

DAP_CAT

Institut de Recerca Hospital de Sant Pau

Àrea de Farmàcia

Biografia

Publicacions

Machine learning models for the prediction of COVID-19 prognosis in the primary health care setting

J. BARROT, J. CAYLÀ, M. MATA-CASES, J. REAL, B. VLACHO, J. FRANCH-NADAL and D. MAURICIO
Bmc Primary Care. 2025 Oct 14; . doi:10.1186/s12875-025-02960-5; PMID:41087937

Veure més:
A study on the utilization of canagliflozin in type 1 diabetes mellitus using real-world data from four European countries

E. VOSS, Z. YUAN, S. ALI, R. BOSAN, E. EWORUKE, J. BREWSTER, B. VLACHO, B. FERNÁNDEZ-CAMINS, S. FERNÁNDEZ-BERTOLÍN, S. FONSECA, C. JEFFCOAT and L. WANG
DIABETES OBESITY & METABOLISM. 2025 Sep 1; . doi:10.1111/dom.16574; PMID:40605139

Veure més:
Hypertriglyceridemia and its relationship with all-cause mortality and pancreatitis: Results from a large retrospective clinical registry.

Vlacho B, Julve J, Genua I, Fernández-Camins B, Real J, Franch-Nadal J, Mauricio D and Ortega E
Journal of Clinical Lipidology. 2025 Aug 1; . doi:10.1016/j.jacl.2025.04.195; PMID:40467441

Veure més:
A deep attention-based encoder for the prediction of type 2 diabetes longitudinal outcomes from routinely collected health care data

E. MANZINI, B. VLACHO, J. FRANCH-NADAL, J. ESCUDERO, A. GÉNOVA, E. REIXACH, E. ANDRÉS, I. PIZARRO, D. MAURICIO and A. PERERA-LLUNA
EXPERT SYSTEMS WITH APPLICATIONS. 2025 May 15; . doi:10.1016/j.eswa.2025.126876;

Veure més:
Clinical characteristics and management of type 2 diabetes in primary care in Spain. SED2 Study

V. ANTONIO-ARQUES, B. CAMINS, B. VLACHO, J. BARROT, J. PÉREZ, E. TORRE, D. MAURICIO and J. FRANCH-NADAL
Endocrinologia Diabetes y Nutricion. 2025 Apr 1; . doi:10.1016/j.endien.2025.501543; PMID:40180835

Veure més:
Characterisation of type 2 diabetes subgroups at diagnosis: the COPERNICAN prospective observational cohort study protocol

B. FERNANDEZ-CAMINS, B. VLACHO, A. CANUDAS, M. ORTEGA, M. GRANADO-CASAS, A. PERERA-LLUNA, A. BOLUDA-SANSON, Y. EL-KHATTABI-OFKIR, J. FRANCH-NADAL and D. MAURICIO
BMJ Open. 2024 Dec 13; . doi:10.1136/bmjopen-2023-083825; PMID:39675821

Veure més:
Incidence of Diabetic Retinopathy in Individuals with Type 2 Diabetes: A Study Using Real-World Data

C. HERNÁNDEZ-TEIXIDÓ, J. DE LA PUENTE, S. JIMÉNEZ, B. FERNÁNDEZ-CAMINS, D. MAURICIO, P. AROCA, B. VLACHO and J. FRANCH-NADAL
Journal of Clinical Medicine. 2024 Dec 1; . doi:10.3390/jcm13237083; PMID:39685542

Veure més:
Impact of Dietary Niacin on Metabolic Dysfunction-Associated Steatotic Liver Disease in Mediterranean Subjects: A Population-Based Study

M. ANTENTAS, M. ROJO-LÓPEZ, P. VENDRELL, M. GRANADO-CASAS, I. GENUA, B. FERNANDEZ-CAMINS, J. ROSSELL, J. NIÑO-NARVIÓN, E. MOREIRA, E. CASTELBLANCO, E. ORTEGA, B. VLACHO, N. ALONSO, D. MAURICIO and J. JULVE
Nutrients. 2024 Dec 1; . doi:10.3390/nu16234178; PMID:39683571

Veure més:
First manifestation of cardiovascular disease according to age and sex in a Mediterranean country.

Ortega E, Genua I, Mata-Cases M, Roqué M, Vlacho B, Real Gatius J, Franch-Nadal J and Mauricio D
Frontiers in Cardiovascular Medicine. 2024 Sep 17; . doi:10.3389/fcvm.2024.1403363; PMID:39355347

Veure més:
Effectiveness of a multicomponent healthcare intervention on blood pressure and lipids among subjects with poorly controlled type 2 diabetes: Findings from the INTEGRA study.

Vlacho B, Molló Iniesta À, Gratacòs M, Mata-Cases M, Rubinat E, Berenguera A, Cos FX, Franch-Nadal J and Mauricio D
Primary Care Diabetes. 2024 Aug 1; . doi:10.1016/j.pcd.2024.05.001; PMID:38782704

Veure més:
Diabetic foot disease carries an intrinsic high risk of mortality and other severe outcomes in type 2 diabetes: a propensity score-matched retrospective population-based study

B. VLACHO, M. BUNDÓ, J. LLUSSÀ, J. REAL, M. MATA-CASES, X. COS, D. TUNDIDOR, F. ZACCARDI, K. KHUNTI, E. JUDE, J. FRANCH-NADAL and D. MAURICIO
Cardiovascular Diabetology. 2024 Jun 19; . doi:10.1186/s12933-024-02303-1; PMID:38898525

Veure més:
Sex-specific disparities in dietary patterns and their association with metabolic-associated fatty liver disease

M. PERAILE, M. ROJO-LÓPEZ, B. VLACHO, J. ROSSELL, P. VENDRELL, I. GENUA, B. FERNÁNDEZ-CAMINS, M. GRANADO-CASAS, D. MAURICIO and J. JULVE
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024 Jun 1;

Veure més:
Sex and age significantly modulate cardiovascular disease presentation in type 2 diabetes: a large population-based cohort study

A. JIMÉNEZ, B. VLACHO, M. MATA-CASES, J. REAL, D. MAURICIO, J. FRANCH-NADAL and E. ORTEGA
Frontiers in Endocrinology. 2024 May 17; . doi:10.3389/fendo.2024.1344007; PMID:38828412

Veure més:
Performance of Primary Care Physicians in the Management of Glycemia, Lipids, and Blood Pressure among People with Type 2 Diabetes: A Cross-Sectional Study

B. VLACHO, B. FERNANDEZ-CAMINS, A. CANUDAS-VENTURA, A. RODRÍGUEZ, A. MOLLO, F. CLARAMUNT, M. ANTENTAS, D. MAURICIO and J. FRANCH-NADAL
Journal of Clinical Medicine. 2024 Mar 1; . doi:10.3390/jcm13061544; PMID:38541770

Veure més:
Trends in the prevalence of gestational diabetes in Catalonia from 2010 to 2019.

B. SOLDEVILA, L. ALARCON, B. VLACHO, J. REAL, M. HERNANDEZ, X. COS, J. FRANCH-NADAL and D. MAURICIO
Primary Care Diabetes. 2024 Jan 15; . doi:10.1016/j.pcd.2023.12.007; PMID:38228411

Veure més:
Clinical characteristics and degree of cardiovascular risk factor control in patients with newly-diagnosed type 2 diabetes in Catalonia.

A. RAMIREZ-MORROS, J. FRANCH-NADAL, J. REAL, Q. MIRO-CATALINA, M. BUNDO, B. VLACHO and D. MAURICIO
Frontiers in Endocrinology. 2024 Jan 1; . doi:10.3389/fendo.2024.1339879; PMID:38390201

Veure més:
Severe hypertriglyceridemia prevalence at a primary care setting in Catalonia, Spain.

Ortega E, Vlacho B, Treserres RP, Mata-Cases M, Altes A, Mauricio D and Franch-Nadal J
Journal of Clinical Lipidology. 2023 Nov 1; . doi:10.1016/j.jacl.2023.09.002; PMID:37741728

Veure més:
Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes.

Simó R, Franch-Nadal J, Vlacho B, Real J, Amado E, Flores J, Mata-Cases M, Ortega E, Rigla M, Vallés JA, Hernández C and Mauricio D
DIABETES CARE. 2023 Sep 1; . doi:10.2337/dc22-2521; PMID:37428631

Veure més:
Rapid reduction of HbA1c and early worsening of diabetic retinopathy: a real-world population-based study in subjects with type 2 diabetes

R. SIMO, J. FRANCH-NADAL, B. VLACHO, J. REAL, E. AMADO, J. FLORES, M. MATA-CASES, E. ORTEGA, M. RIGLA, J. VALLÉS, C. HERNÁNDEZ and D. MAURICIO
Diabetologia. 2023 Sep 1;

Veure més:
A multicomponent health care intervention is associated with improved glycaemic control in subjects with poorly controlled type 2 diabetes compared with routine care: The INTEGRA study

A. MOLLO, B. VLACHO, M. GRATACOS, M. MATA-CASES, E. RUBINAT, A. OSSO, F. COS, J. FRANCH-NADAL, K. KHUNTI and D. MAURICIO
DIABETES OBESITY & METABOLISM. 2023 Aug 22; . doi:10.1111/dom.15250; PMID:37608473

Veure més:
SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe

L. PENNELLS, S. KAPTOGE, H. OSTERGAARD, S. READ, F. CARINCI, J. FRANCH-NADAL, C. PETITJEAN, O. TAYLOR, S. HAGEMAN, Z. XU, F. SHI, S. SPACKMAN, S. GUALDI, N. HOLMAN, R. COSTA, F. BONNET, H. BRENNER, S. KIECHL, D. LAWLOR, L. POTIER, B. SCHÖTTKER, R. SOFAT, H. VÖLZKE, J. WILLEIT, Z. BALTANE, S. FAVA, S. JANOS, A. LAVENS, S. PILDAVA, T. POLJICANIN, I. PRISTAS, P. ROSSING, R. SASCHA, C. SCHEIDT-NAVE, I. STOTL, G. TIBOR, V. URBANCIC-ROVAN, A. VANHERWEGEN, D. VISTISEN, Y. DU, M. WALKER, P. WILLEIT, B. FERENCE, D. DE BACQUER, M. HALLE, R. HUCULECI, J. MCEVOY, A. TIMMIS, P. VARDAS, J. DORRESTEIJN, I. GRAHAM, A. WOOD, B. ELIASSON, W. HERRINGTON, J. DANESH, D. MAURICIO, M. BENEDETTI, N. SATTAR, F. VISSEREN, S. WILD, E. DI ANGELANTONIO, B. BALKAU, F. FUMERON, H. STOCKER, B. HOLLECZEK, S. SCHIPF, C. SCHMIDT, M. DOERR, H. TILG, C. LEITNER, M. NOTDURFTER, J. TAYLOR, C. DALE, D. PRIETO-MERINO, R. GILLUM, T. BUBLE, P. IVANKO, B. CARSTENSEN, C. HEIDEMANN, T. GALL, J. SANDOR, J. LEPIKSONE, C. MAGRI, J. AZZOPARDI, J. REAL, B. VLACHO and M. MATA-CASES
EUROPEAN HEART JOURNAL. 2023 Jul 21; . doi:10.1093/eurheartj/ehad260; PMID:37247330

Veure més:
Epidemiology of the first-ever cardiovascular event in people with type 1 diabetes: a retrospective cohort population-based study in Catalonia

G. GIMENEZ-PEREZ, C. VINALS, M. MATA-CASES, B. VLACHO, J. REAL, J. FRANCH-NADAL, E. ORTEGA and D. MAURICIO
Cardiovascular Diabetology. 2023 Jul 14; . doi:10.1186/s12933-023-01917-1; PMID:37452416

Veure més:
Rapid Reduction of HbA1c and EarlyWorsening of Diabetic Retinopathy: A Real-world Population-based Study in Subjects with Type 2 Diabetes

R. SIMÓ, J. FRANCH-NADAL, B. VLACHO, J. REAL, E. AMADO, M. MATA-CASES, J. VALLÉS, D. MAURICIO and C. HERNÁNDEZ
EUROPEAN JOURNAL OF OPHTHALMOLOGY. 2023 May 1;

Veure més:
Impact of a multicomponent healthcare intervention on glycaemic control in subjects with poorly controlled type 2 diabetes: The INTEGRA study

A. MOLLO, B. VLACHO, M. GRATACOS, M. MATA-CASES, E. RUBINAT, A. BERENGUERA, J. REAL, R. PUIG-TRESERRA, X. COS, J. FRANCH-NADAL, K. KHUNTI, D. MAURICIO and INTEGRA Res grp
DIABETES OBESITY & METABOLISM. 2023 Apr 1; . doi:10.1111/dom.14951; PMID:36546592

Veure més:
Adherence to the therapeutic guidelines recommendations among the people with type 2 diabetes mellitus and obesity, frailty, or recent diagnosis, attended in primary health care centers in Spain: A cross-sectional study

B. VLACHO, M. MATA-CASES, B. FERNANDEZ-CAMINS, L. LIEBANA, J. BARROT-DE LA PUENTE and J. FRANCH-NADAL
Frontiers in Medicine. 2023 Mar 24; . doi:10.3389/fmed.2023.1138956; PMID:37035300

Veure més:
Prediction of outcomes in subjects with type 2 diabetes and diabetic foot ulcers in Catalonian primary care centers: a multicenter observational study

M. BUNDO, B. VLACHO, J. LLUSSA, I. BOBE, M. AIVAR, C. CIRIA, A. MARTINEZ-SANCHEZ, J. REAL, M. MATA-CASES, X. COS, M. DORIA, J. VIADE, J. FRANCH-NADAL and D. MAURICIO
Journal of Foot and Ankle Research. 2023 Feb 28; . doi:10.1186/s13047-023-00602-6; PMID:36849888

Veure més:
Outcome of COVID-19 infection in people with diabetes mellitus or obesity in the primary care setting in Catalonia, Spain: A retrospective cohort study of the initial three waves

Mauricio D, Vlacho B, Ortega E, Cos-Claramunt X, Mata-Cases M, Real J, Fernandez-Camins B and Franch-Nadal J
Primary Care Diabetes. 2023 Feb 1; . doi:10.1016/j.pcd.2022.12.002; PMID:36528549

Veure més:
All-cause and cardiorenal mortality in 6 million adults with and without type 2 diabetes: A comparative, trend analysis in Canada, Spain, and the UK

S. LING, F. ZACCARDI, B. VLACHO, P. LI, J. GATIUS, M. MATA-CASES, J. FRANCH-NADAL, M. KOSIBOROD, C. GILLIES, P. FENICI, D. MAURICIO, B. SHAH and K. KHUNTI
DIABETES OBESITY & METABOLISM. 2023 Jan 1; . doi:10.1111/dom.14856; PMID:36056765

Veure més:
Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia

I. GENUA, J. FRANCH-NADAL, E. NAVAS, M. MATA-CASES, G. GIMENEZ-PEREZ, B. VLACHO, D. MAURICIO and A. GODAY
Frontiers in Endocrinology. 2022 Dec 2; . doi:10.3389/fendo.2022.1015614; PMID:36531459

Veure més:
Adherence to antidiabetic treatment among patients managed in primary care centres in Spain: the INTENSE study

B. VLACHO, F. SIMARRO, M. MATA-CASES, S. MIRAVET, J. ESCRIBANO-SERRANO, D. ASENSIO, X. CORTES and J. FRANCH-NADAL
Primary Care Diabetes. 2022 Dec 1; . doi:10.1016/j.pcd.2022.10.004; PMID:36335018

Veure més:
Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world

J. FRANCH-NADAL, M. GRANADO-CASAS, M. MATA-CASES, E. ORTEGA, B. VLACHO and D. MAURICIO
Primary Care Diabetes. 2022 Dec 1; . doi:10.1016/j.pcd.2022.10.005; PMID:36336605

Veure més:
Glycemic control and the risk of tuberculosis in patients with diabetes: A cohort study in a Mediterranean city

V. ANTONIO-ARQUES, J. CAYLA, J. REAL, A. MORENO-MARTINEZ, A. ORCAU, D. MAURICIO, M. MATA-CASES, J. JULVE, E. MENDEZ, R. TRESERRA, J. MILLET, J. GARCIA, B. VLACHO and J. FRANCH-NADAL
Frontiers in Public Health. 2022 Nov 17; . doi:10.3389/fpubh.2022.1017024; PMID:36466495

Veure més:
Longitudinal deep learning clustering of Type 2 Diabetes Mellitus trajectories using routinely collected health records

E. MANZINI, B. VLACHO, J. FRANCH-NADAL, J. ESCUDERO, A. GENOVA, E. REIXACH, E. ANDRES, I. PIZARRO, J. PORTERO, D. MAURICIO and A. PERERA-LLUNA
JOURNAL OF BIOMEDICAL INFORMATICS. 2022 Nov 1; . doi:10.1016/j.jbi.2022.104218; PMID:36216232

Veure més:
Prevalence and risk factors of diabetic foot disease among the people with type 2 diabetes using real-world practice data from Catalonia during 2018

M. BUNDO, B. VLACHO, J. LLUSSA, R. PUIG-TRESERRA, M. MATA-CASES, X. COS, E. JUDE, J. FRANCH-NADAL and D. MAURICIO
Frontiers in Endocrinology. 2022 Oct 24; . doi:10.3389/fendo.2022.1024904; PMID:36353236

Veure més:
Comorbid autoimmune diseases and burden of diabetes-related complications in patients with type 1 diabetes from a Mediterranean area

G. GIMENEZ-PEREZ, B. VLACHO, E. NAVAS, M. MATA-CASES, J. REAL, X. COS, J. FRANCH-NADAL and D. MAURICIO
DIABETES RESEARCH AND CLINICAL PRACTICE. 2022 Sep 1; . doi:10.1016/j.diabres.2022.110031; PMID:35934173

Veure més:
Potential Risk of Overtreatment in Patients with Type 2 Diabetes Aged 75 Years or Older: Data from a Population Database in Catalonia, Spain

M. MATA-CASES, D. MAURICIO, J. REAL, B. VLACHO, L. ROMERA-LIEBANA, N. MOLIST-BRUNET, M. CEDENILLA and J. FRANCH-NADAL
Journal of Clinical Medicine. 2022 Sep 1; . doi:10.3390/jcm11175134; PMID:36079064

Veure més:
Diabetic retinopathy as a predictor of cardiovascular morbidity and mortality in subjects with type 2 diabetes

J. BARROT, J. REAL, B. VLACHO, P. ROMERO-AROCA, R. SIMO, D. MAURICIO, M. MATA-CASES, E. CASTELBLANCO, X. MUNDET-TUDURI and J. FRANCH-NADAL
Frontiers in Medicine. 2022 Aug 16; . doi:10.3389/fmed.2022.945245; PMID:36052329

Veure més:
Subjects With Diabetes Mellitus Are at Increased Risk for Developing Tuberculosis: A Cohort Study in an Inner-City District of Barcelona (Spain)

V. ANTONIO-ARQUES, J. FRANCH-NADAL, A. MORENO-MARTINEZ, J. REAL, A. ORCAU, D. MAURICIO, M. MATA-CASES, J. JULVE, E. MENDEZ, R. TRESERRA, J. DE LA PUENTE, J. MILLET, J. GARCIA, B. VLACHO and J. CAYLA
Frontiers in Public Health. 2022 May 23; . doi:10.3389/fpubh.2022.789952; PMID:35677764

Veure més:
Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European study.

Harris S, Ruan Y, Wild SH, Wargny M, Hadjadj S, Delasalle B, Saignes M, Ryder RE, Field BCT, Narendran P, Zaccardi F, Wilmot EG, Vlacho B, Llauradó G, Mauricio D, Nagi D, Patel D, Várnai KA, Davies J, Gourdy P, Cariou B, Rea R and Khunti K
Diabetes & Metabolic Syndrome. 2022 May 1; . doi:10.1016/j.dsx.2022.102484; PMID:35472685

Veure més:
Compliance with the DPP-4 inhibitors dose adjustment recommendations based on renal function in a population database.

Franch-Nadal J, Gatius JR, Mata-Cases M, Ortega E, Valles JA, Vlacho B and Mauricio D
Endocrinologia Diabetes y Nutricion. 2022 Feb 28; . doi:10.1016/j.endien.2022.02.011; PMID:35256063

Veure més:
Compliance with the DPP-4 inhibitors dose adjustment recommendations based onrenal function in a population database

J. FRANCH-NADAL, J. REAL, M. MATA-CASES, E. ORTEGA, J. VALLES, B. VLACHO and D. MAURICIO
Endocrinologia Diabetes y Nutricion. 2022 Feb 1; . doi:10.1016/j.endinu.2021.01.013; PMID:34088634

Veure més:
Associations Between Diabetic Retinopathy and Parkinson’s Disease: Results From the Catalonian Primary Care Cohort Study

D. MAURICIO, B. VLACHO, J. DE LA PUENTE, X. MUNDET-TUDURI, J. REAL, J. KULISEVSKY, E. ORTEGA, E. CASTELBLANCO, J. JULVE and J. FRANCH-NADAL
Frontiers in Medicine. 2022 Jan 18; . doi:10.3389/fmed.2021.800973; PMID:35118094

Veure més:
Trends in the Degree of Control and Treatment of Cardiovascular Risk Factors in People With Type 2 Diabetes in a Primary Care Setting in Catalonia During 2007-2018

M. MATA-CASES, B. VLACHO, J. REAL, R. PUIG-TRESERRA, M. BUNDO, J. FRANCH-NADAL and D. MAURICIO
Frontiers in Endocrinology. 2022 Jan 10; . doi:10.3389/fendo.2021.810757; PMID:35082758

Veure més:
Incidence and characteristics of diabetic foot ulcers in subjects with type 2 diabetes in Catalonian primary care centres: An observational multicentre study

M. BUNDO, J. LLUSSA, M. SERRA, P. DE LA IGLESIA, R. GIMBERT, J. REAL, B. VLACHO, M. MATA-CASES, X. COS, J. FRANCH-NADAL and D. MAURICIO
Primary Care Diabetes. 2021 Dec 1; . doi:10.1016/j.pcd.2021.08.002; PMID:34419365

  • Any: 01/12/2021
  • FI: 2.567
  • Article

Veure més:
Previous Vitamin D Supplementation and Morbidity and Mortality Outcomes in People Hospitalised for COVID19: A Cross-Sectional Study

J. ARROYO-DIAZ, J. JULVE, B. VLACHO, R. CORCOY, P. PONTE, E. ROMAN, E. NAVAS-MENDEZ, G. LLAURADO, J. FRANCH-NADAL, P. DOMINGO and D. MAURICIO
Frontiers in Public Health. 2021 Sep 24; . doi:10.3389/fpubh.2021.758347; PMID:34631653

  • Any: 24/09/2021
  • FI: 6.461
  • Article

Veure més:
Analysis of the Adherence and Safety of Second Oral Glucose-Lowering Therapy in Routine Practice From the Mediterranean Area: A Retrospective Cohort Study

B. VLACHO, M. MATA-CASES, X. MUNDET-TUDURI, J. VALLES-CALLOL, J. REAL, M. FARRE, X. COS, K. KHUNTI, D. MAURICIO and J. FRANCH-NADAL
Frontiers in Endocrinology. 2021 Jul 14; . doi:10.3389/fendo.2021.708372; PMID:34335477

  • Any: 14/07/2021
  • FI: 6.055
  • Article

Veure més:
Cardiovascular and mortality benefits of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-Real Catalonia

J. REAL, B. VLACHO, E. ORTEGA, J. VALLES, M. MATA-CASES, E. CASTELBLANCO, E. WITTBRODT, P. FENICI, M. KOSIBOROD, D. MAURICIO and J. FRANCH-NADAL
Cardiovascular Diabetology. 2021 Jul 9; . doi:10.1186/s12933-021-01323-5; PMID:34243779

  • Any: 09/07/2021
  • FI: 8.949
  • Article

Veure més:
Evaluation of clinical and antidiabetic treatment characteristics of different sub-groups of patients with type 2 diabetes: Data from a Mediterranean population database

M. MATA-CASES, J. FRANCH-NADAL, J. REAL, B. VLACHO, A. GOMEZ-GARCIA and D. MAURICIO
Primary Care Diabetes. 2021 Jun 1; . doi:10.1016/j.pcd.2021.02.003; PMID:33602606

  • Any: 01/06/2021
  • FI: 2.567
  • Article

Veure més:
Clinical Characteristics and Degree of Glycemic and Cardiovascular Risk Factor Control in Patients with Type 1 Diabetes in Catalonia (Spain)

G. GIMENEZ-PEREZ, J. FRANCH-NADAL, E. ORTEGA, M. MATA-CASES, A. GODAY, J. REAL, A. RODRIGUEZ, B. VLACHO and D. MAURICIO
Journal of Clinical Medicine. 2021 Apr 1; . doi:10.3390/jcm10071536; PMID:33917523

  • Any: 01/04/2021
  • FI: 4.964
  • Article

Veure més:
Risk factors for severe outcomes in people with diabetes hospitalised for COVID-19: a cross-sectional database study

E. ORTEGA, R. CORCOY, M. GRATACOS, F. CLARAMUNT, M. MATA-CASES, R. PUIG-TRESERRA, J. REAL, B. VLACHO, E. CASTELBLANCO, P. DOMINGO, K. KHUNTI, J. FRANCH-NADAL and D. MAURICIO
BMJ Open. 2021 Jan 1; . doi:10.1136/bmjopen-2021-051237; PMID:34301668

  • Any: 01/01/2021
  • FI: 3.006
  • Article

Veure més:
Analysis of the effectiveness of second oral glucose-lowering therapy in routine clinical practice from the mediterranean area: A retrospective cohort study

B. VLACHO, X. MUNDET-TUDURI, M. MATA-CASES, J. VALLES-CALLOL, J. REAL, M. FARRE, F. COS, K. KHUNTI, D. MAURICIO and J. FRANCH-NADAL
DIABETES RESEARCH AND CLINICAL PRACTICE. 2021 Jan 1; . doi:10.1016/j.diabres.2020.108616; PMID:33310172

Veure més:
The Association Between Poor Glycemic Control and Health Care Costs in People With Diabetes: A Population-Based Study

M. MATA-CASES, B. RODRIGUEZ-SANCHEZ, D. MAURICIO, J. REAL, B. VLACHO, J. FRANCH-NADAL and J. OLIVA
DIABETES CARE. 2020 Apr 1; . doi:10.2337/dc19-0573; PMID:32029636

  • Any: 01/04/2020
  • FI: 19.112
  • Article

Veure més:
Poor awareness among health care professionals about gender differences in the relationship between type 2 diabetes mellitus and cardiovascular disease

P. BUIL-COSIALES, C. GOMEZ-GARCIA, X. COS, J. FRANCH-NADAL, B. VLACHO and J. MILLARUELO
MEDICINA DE FAMILIA-SEMERGEN. 2020 Mar 1; . doi:10.1016/j.semerg.2019.10.002; PMID:31831323

Veure més:
Randomized placebo-controlled clinical trial on efficacy and safety of topical 10% Potassium hydroxide for molluscum contagiosum treatment in children

M. GINER-SORIANO, C. TEIXIDO, J. MARSAL, O. DIEZ, H. PERA, B. VLACHO, R. MORROS, S. MUNOZ, M. FOLCH, G. MANRIQUE, M. MORENO, M. CRESPO, M. VERGARA, T. ICHAZO, I. IBANEZ, M. SANCHEZ, M. ROBLES, M. EGUILUZ, A. COLELL, M. MANGADO, G. FURIO, A. DE ASPRER, E. MARTINEZ, J. RIART, C. YCHART, R. ATIENZA and D. LAMOTTE
JOURNAL OF DERMATOLOGICAL TREATMENT. 2019 Nov 17; . doi:10.1080/09546634.2019.1573305; PMID:30668179

  • Any: 17/11/2019
  • FI: 2.156
  • Article

Veure més:
Glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes:real-world evidence from a Mediterranean area

M. MATA-CASES, J. FRANCH-NADAL, E. ORTEGA, J. REAR, M. GRATACOS, B. VLACHO and D. MAURICIO
CURRENT MEDICAL RESEARCH AND OPINION. 2019 Oct 3; . doi:10.1080/03007995.2019.1618806; PMID:31081693

  • Any: 03/10/2019
  • FI: 2.271
  • Article

Veure més:
Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: Prescription According to Reimbursement Constraints and Guideline Recommendations in Catalonia

J. FRANCH-NADAL, M. MATA-CASES, E. ORTEGA, J. REAL, M. GRATACOS, B. VLACHO, J. VALLES and D. MAURICIO
Journal of Clinical Medicine. 2019 Sep 1; . doi:10.3390/jcm8091389; PMID:31491916

  • Any: 01/09/2019
  • FI: 3.303
  • Article

Veure més:
Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world setting

S. CANIVELL, M. MATA-CASES, J. REAL, J. FRANCH-NADAL, B. VLACHO, K. KHUNTI, M. GRATACOS and D. MAURICIO
DIABETES OBESITY & METABOLISM. 2019 Jun 1; . doi:10.1111/dom.13663; PMID:30756446

Veure més:
INTEGRA study protocol: primary care intervention in type 2 diabetes patients with poor glycaemic control

A. MOLLO, A. BERENGUERA, E. RUBINAT, B. VLACHO, M. MATA, J. FRANCH, B. BOLIBAR and D. MAURICIO
BMC Family Practice. 2019 Feb 7; . doi:10.1186/s12875-019-0916-9; PMID:30732583

  • Any: 07/02/2019
  • FI: 2.022
  • Article

Veure més:
Glycaemic control and treatment of type 2 diabetes in adults aged 75 years or older

A. RODRIGUEZ-PONCELAS, J. BARROT-DE LA-PUENTE, G. DE TUERO, C. LOPEZ-ARPI, B. VLACHO, F. LOPEZ-SIMARRO, X. TUDURI and J. FRANCH-NADAL
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 2018 Mar 1; . doi:10.1111/ijcp.13075; PMID:29512235

  • Any: 01/03/2018
  • FI: 2.613
  • Article

Veure més:
Dabigatran and vitamin K antagonists’ use in na < ve patients with non-valvular atrial fibrillation: a cross-sectional study of primary care-based electronic health records

B. VLACHO, M. GINER-SORIANO, E. ZABALETA-DEL-OLMO, A. ROSO-LLORACH, A. GARCIA-SANGENIS and R. MORROS-PEDROS
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2017 Oct 1; . doi:10.1007/s00228-017-2305-4; PMID:28725983

  • Any: 01/10/2017
  • FI: 2.679
  • Article

Veure més:
Safety of the reuse of needles for subcutaneous insulin injection: A systematic review and meta-analysis

E. ZABALETA-DEL-OLMO, B. VLACHO, L. JODAR-FERNANDEZ, A. URPI-FERNANDEZ, I. LUMILLO-GUTIERREZ, J. AGUDO-UGENA, R. MORROS-PEDROS and C. VIOLAN
INTERNATIONAL JOURNAL OF NURSING STUDIES. 2016 Aug 1; . doi:10.1016/j.ijnurstu.2016.04.010; PMID:27297374

  • Any: 01/08/2016
  • FI: 3.755
  • Article

Veure més:
Chronic kidney disease screening in primary care: a descriptive analysis of the Girona Sud health region.

Barrot-de la Puente J, Lopez Arpí C, Ramon Granes M, Escribà Planes M, Fernandez-Camins B, Vlacho B and Franch-Nadal J
Bmc Primary Care. . doi:10.1186/s12875-025-03117-0; PMID:41276836

Veure més:
Incretin-based Agents and Metabolic Dysfunction-associated Steatotic Liver Disease.

Muzurovic E, Haluzik M, Horváth L, Vlacho B and Mauricio D
CURRENT PHARMACEUTICAL DESIGN. . doi:10.2174/0113816128378484250619080753; PMID:40641020

Veure més:

Patronat

Col·laboradors

Acreditacions